Stimulus-dependent alterations in quantal neurotransmitter release.
Neurotransmitter release is a steep function of the intracellular calcium ion concentration ([Ca(2+)](i)) at the release sites. Both the Ca(2+) amplitude and the time course appear to be important for specifying neurotransmitter release. Ca(2+) influx regulates the number of vesicles exocytosed as well as the amount of neurotransmitter each individual vesicle releases. In our study we stimulated mouse chromaffin cells in two different ways to alter Ca(2+) presentation at the release sites. One method, digitonin permeabilization followed by exposure to Ca(2+), allows for a large uniform global elevation of [Ca(2+)](i), whereas the second method, application of nicotine, depolarizes chromaffin cells and activates voltage-dependent Ca(2+) channels, thereby producing more phasic and localized changes in [Ca(2+)](i). Using amperometry to monitor catecholamine release, we show that both kinds of stimuli elicit the exocytosis of similar quantities of neurotransmitter per large dense core vesicles (LDCVs) released. Even so, the release process was quite different for each stimulus; nicotine-elicited events were small and slow, whereas digitonin events were, in comparison, large and fast. In addition, the transient opening of the fusion pore, called the "foot," was essentially absent in digitonin-stimulated cells, but was quite common in nicotine-stimulated cells. Thus even though both strong stimuli used in this study elicited the release of many vesicles it appears that the differences in the Ca(2+) levels at the release sites were key determinants for the fusion and release of individual vesicles.
Grabner
Chad P
CP
Department of Cellular and Molecular Physiology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06511, USA. cpg22@email.med.yale.edu
Fox
Aaron P
AP
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D019439:Chromaffin Cells / Q000187:drug effects / Q000378:metabolism; D004072:Digitonin / Q000494:pharmacology; D004558:Electric Stimulation; D004594:Electrophysiology; D005089:Exocytosis / Q000187:drug effects; D066298:In Vitro Techniques; D051379:Mice; D018377:Neurotransmitter Agents / Q000378:metabolism*; D009538:Nicotine / Q000494:pharmacology; D018722:Nicotinic Agonists / Q000494:pharmacology; D013268:Stimulation, Chemical; D013572:Synaptic Vesicles / Q000187:drug effects / Q000378:metabolism
D002395:Catecholamines; D018377:Neurotransmitter Agents; D018722:Nicotinic Agonists; D009538:Nicotine; D004072:Digitonin; D002118:Calcium